+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

U.S. Intraoperative Neuromonitoring Market by Source Type Product & Service Application Modality and End User - Opportunity Analysis and Industry Forecast, 2014-2022

  • ID: 4621215
  • Report
  • October 2018
  • Region: United States
  • 148 pages
  • Allied Analytics LLP
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now
The U.S. intraoperative neuromonitoring (IONM) market generated $1,239 million in 2015 and is projected to reach $1,938 million by 2022, growing at a CAGR of 6.6% from 2016 to 2022. Intraoperative neurophysiological monitoring (IONM) or intraoperative neuromonitoring is a technique to reduce the risk of neurological deficits after surgical procedures that involve the nervous system. IONM utilizes recordings of electrical potentials from the nervous system during surgical procedures. Neuromonitoring is useful because it offers an opportunity to detect injuries before they become severe. Therefore, with the introduction of IONM, the risk of debilitating deficits, such as muscle weakness, paralysis, hearing loss, and other loss of normal body functions, is reduced.

The U.S. IONM market is expected to grow at a significant rate during the forecast period, owing to growth in the aging population, increase in prevalence of chronic disorders, surge in applications of IONM in different surgeries, and rise in risk management through IONM during complex surgeries. Furthermore, stringent regulations for IONM procedures and easy availability of technologically advanced IONM systems & accessories fuel the market growth.

The U.S. IONM market is studied based on product & service, source type, application, modality, end user, and state. Based on product & service, the market is segmented into system, accessory, and service. On the basis of source type, the market is bifurcated into insourced monitoring and outsourced monitoring. As per end user, the market is categorized into hospital and ambulatory surgical center (ASC). IONM finds its application in spinal surgery, neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, and other surgeries related to the central or peripheral nervous system. IONM modalities include motor evoked potential (MEP), somatosensory evoked potential (SSEP), electroencephalography (EEG), electromyography (EMG), brainstem auditory evoked potential (BAEP), and visual evoked potential (VEP). As per state, the market is analyzed across California, Texas, New York, Florida, Illinois, Colorado, Louisiana, Michigan, Oklahoma, and Rest of the U.S.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all states of the U.S. is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the U.S. market.

KEY MARKET SEGMENTS

By Product & Service

System
Accessory
Service

By Source Type

Insourced monitoring
Outsourced monitoring

By Application

Spinal surgery
Neurosurgery
Vascular surgery
ENT surgery
Orthopedic surgery
Other surgery

By Modality

Motor evoked potential (MEP)
Somatosensory evoked potential (SSEP)
Electroencephalography (EEG)
Electromyography (EMG)
Brainstem auditory evoked potential (BAEP)
Visual evoked potential (VEP)

By End User

Hospital
Ambulatory surgery center

By State

California
Texas
New York
Florida
Illinois
Colorado
Louisiana
Michigan
Oklahoma
Rest of the U.S.

LIST OF KEY PLAYERS PROFILED IN THE REPORT

Accurate Monitoring, LLC.
Computational Diagnostics, Inc.
Intranerve, LLC.
Inomed Medizintechnik GmbH
Medtronic Plc
Moberg Research, Inc. (DAYONE MEDICAL, LLC.)
Natus Medical Incorporated
Nihon Kohden Corporation
Nuvasive, Inc.
Specialtycare

LIST OF OTHER PLAYERS IN THE VALUE CHAIN(These players are not profiled in the report. The same will be included on request.)

Medsurant Health
Abea Neurodiagnostics, Inc.
Real Time Neuromonitoring Associates
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.1.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Top player positioning, 2015
3.3. IONM PROCEDURES IN U.S., BY YEAR
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Increase in prevalence of chronic disorders
3.4.1.2. Surge in U.S. geriatric population
3.4.1.3. Risk management through IONM during complex surgeries
3.4.2. Restraint
3.4.2.1. Additional expenses associated with the insourced monitoring
3.4.3. Opportunity
3.4.3.1. Increase in application of IONM in different surgeries
3.4.4. Impact Analyses

CHAPTER 4: U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Insourced monitoring
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.3. Outsourced monitoring
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast

CHAPTER 5: U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCT & SERVICES
5.1. Overview
5.1.1. Market size and forecast
5.2. System
5.2.1. Market size and forecast
5.3. Accessory
5.3.1. Market size and forecast
5.4. IONM service
5.4.1. Market size and forecast

CHAPTER 6: U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY
6.1. Overview
6.1.1. Market size and forecast
6.2. Motor evoked potentials (MEPs)
6.2.1. Market size and forecast
6.3. Somatosensory evoked potentials (SSEPs)
6.3.1. Market size and forecast
6.4. Electroencephalography (EEG)
6.4.1. Market size and forecast
6.5. Electromyography (EMG)
6.5.1. Market size and forecast
6.6. Brainstem auditory evoked potentials (BAEPs)
6.6.1. Market size and forecast
6.7. Visual evoked potentials (VEPs)
6.7.1. Market size and forecast

CHAPTER 7: U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION
7.1. Overview
7.1.1. Market size and forecast
7.2. Spinal surgery
7.2.1. Market size and forecast
7.3. Neurosurgery
7.3.1. Market size and forecast
7.4. Orthopedic surgery
7.4.1. Market size and forecast
7.5. ENT surgery
7.5.1. Market size and forecast
7.6. Vascular surgery
7.6.1. Market size and forecast
7.7. Other surgeries
7.7.1. Market size and forecast

CHAPTER 8: U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER
8.1. Overview
8.1.1. Market size and forecast
8.2. Hospital
8.2.1. Market size and forecast
8.3. Ambulatory surgery Center
8.3.1. Market size and forecast

CHAPTER 9: U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY STATE
9.1. Overview
9.1.1. Market size and forecast
9.2. California
9.2.1. California IONM market, by application
9.2.2. California IONM accessory market
9.3. Texas
9.3.1. Texas IONM market, by application
9.3.2. Texas IONM accessory market
9.4. New York
9.4.1. New York IONM market, by application
9.4.2. New York IONM accessory market
9.5. Florida
9.5.1. Florida IONM market, by application
9.5.2. Florida IONM accessory market
9.6. Illinois
9.6.1. Illinois IONM market, by application
9.6.2. Illinois IONM accessory market
9.7. Colorado
9.7.1. Colorado IONM market, by application
9.7.2. Colorado IONM accessory market
9.8. Louisiana
9.8.1. Louisiana IONM market, by application
9.8.2. Louisiana IONM accessory market
9.9. Michigan
9.9.1. Michigan IONM market, by application
9.9.2. Michigan IONM accessory market
9.10. Oklahoma
9.10.1. Oklahoma IONM market, by application
9.10.2. Oklahoma IONM accessory market
9.11. Rest of the U.S.
9.11.1. Rest of the U.S. IONM market, by application
9.11.2. Rest of the U.S. IONM accessory market

CHAPTER 10: COMPANY PROFILES
10.1. Accurate Monitoring LLC
10.1.1. Company overview
10.1.2. Company snapshot
10.1.3. Operating business segments
10.1.4. Product portfolio
10.1.5. Business performance
10.2. Computational Diagnostics, Inc.
10.2.1. Company overview
10.2.2. Company snapshot
10.2.3. Operating business segments
10.2.4. Product portfolio
10.2.5. Business performance
10.3. IntraNerve, LLC
10.3.1. Company overview
10.3.2. Company snapshot
10.3.3. Operating business segments
10.3.4. Product portfolio
10.3.5. Business performance
10.4. Inomed Medizintechnik GmbH
10.4.1. Company overview
10.4.2. Company snapshot
10.4.3. Operating business segments
10.4.4. Product portfolio
10.4.5. Business performance
10.4.6. Key strategic moves and developments
10.5. Medtronic plc.
10.5.1. Company overview
10.5.2. Company snapshot
10.5.3. Operating business segments
10.5.4. Product portfolio
10.5.5. Business performance
10.6. Morberg Research, Inc. (Dayone Medical, LLC.)
10.6.1. Company overview
10.6.2. Company snapshot
10.6.3. Operating business segments
10.6.4. Product portfolio
10.6.5. Business performance
10.7. Natus Medical Incorporated
10.7.1. Company overview
10.7.2. Company snapshot
10.7.3. Operating business segments
10.7.4. Product portfolio
10.7.5. Business performance
10.7.6. Key strategic moves and developments
10.8. Nihon Kohden Corporation
10.8.1. Company overview
10.8.2. Company snapshot
10.8.3. Operating business segments
10.8.4. Product portfolio
10.8.5. Business performance
10.8.6. Key strategic moves and developments
10.9. NuVasive, Inc.
10.9.1. Company overview
10.9.2. Company snapshot
10.9.3. Operating business segments
10.9.4. Product portfolio
10.9.5. Key strategic moves and developments
10.10. SpecialtyCare
10.10.1. Company overview
10.10.2. Company snapshot
10.10.3. Operating business segments
10.10.4. Product portfolio
10.10.5. Business performance
10.10.6 Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to a new report titled, U.S. Intraoperative Neuromonitoring Market, by Source Type, Product & Service, Modality, Application, and End User: Opportunity Analysis and Industry Forecast, 2016-2022," the U.S. intraoperative neuromonitoring (IONM) market generated $1,239 million in 2015 and is projected to reach $1,938 million by 2022, growing at a CAGR of 6.6% from 2016 to 2022.

The IONM system segment accounted for nearly half of the total market in 2015. These systems help to identify neural structures during a surgery. This helps the surgeons to prevent any damage to the nervous system, which may be caused during the surgery and also reduce post-operative complications. The U.S. IONM market is driven by rise in number of surgeries, increase in geriatric population, growth in prevalence of chronic disorders, and surge in adoption of IONM during complex surgeries.

Based on source type, the U.S. IONM market is bifurcated as outsourced monitoring and insourced monitoring. The outsourced monitoring segment is expected to grow at the highest CAGR, owing to its benefits over insourced monitoring. At present, hospitals generally do not prefer insourced monitoring as they have to appoint a full-time employee with the required skill set, and they cannot offer the training standardization to improve the quality of service. Thus, outsourced monitoring is in demand among hospitals and ambulatory surgical centers (ASCs).

Based on product & service, the U.S. IONM market is categorized as system, accessory, and service. The system segment dominates the U.S. IONM market, owing to its critical role in every IONM procedure. On the other side, the service segment is expected to exhibit the fastest market growth during the forecast period, owing to increase in demand for IONM service providers. Based on modality, the U.S. IONM market is segmented into somatosensory evoked potential (SSEP), motor evoked potential (MEP), electromyography (EMG), electroencephalography (EEG), visual evoked potential (VEP), and brainstem auditory evoked potential (BAEP). The EMG segment was the major revenue contributor in 2015 and is estimated to remain dominant during the forecast period, owing to its applicability in complex surgery. However, the BAEP segment is expected to show the fastest market growth during the forecast period, owing to technological advancements and rise in adoption of BAEPs.

Based on application, the U.S. IONM market is categorized into spinal surgery, neurosurgery, orthopedic surgery, ENT surgery, vascular surgery, and other surgeries. The spinal surgery segment was the highest revenue contributor to the U.S. IONM market in 2015, owing to increase in number of spinal surgeries in the U.S and recommended use of IONM during spinal surgery. However, the orthopedic surgery segment is projected to exhibit the fastest market growth during the forecast period, owing to increase in adoption of IONM during orthopedic surgery.

Based on end user, the U.S. IONM market is classified into hospital and ambulatory surgical center (ASC). The hospital segment was the major revenue contributor in 2015, owing to increase in number of hospitals, growth in number of surgeries, and rise in outsourced monitoring within hospitals. However, the ambulatory surgery center segment is expected to exhibit rapid growth during the forecast period, owing to rise in number of surgeries within ambulatory surgery centers.

Key Findings of the U.S. Intraoperative Neuromonitoring Market:

Based on application, the spinal surgery segment accounted for more than one-fourth of the total market in 2015.
As per modality, the electromyography (EMG) segment accounted for more than one-fourth of the U.S. market in 2015.
According to product & service, the IONM service segment is expected to grow at a high CAGR of 9.4% during the forecast period, owing to an increase in the demand for IONM service providers.
On the basis of end user, the hospital segment accounted for nearly half of the total market share in 2015.

The key players profiled in this report include Accurate Monitoring, LLC., Computational Diagnostics, Inc., Intranerve, LLC., Inomed Medizintechnik GmbH, Medtronic Plc, Moberg Research, Inc. (Dayone Medical, LLC.), Natus Medical Incorporated, Nihon Kohden Corporation, Nuvasive, Inc., and Specialtycare.
Note: Product cover images may vary from those shown
5 of 4

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll